Figure S2. Related to Figure 2. Eyeblink responses during the conditioned stimulus
To examine the effect of chemogenetic manipulation on non-selective eyeblink responses, EMG activity during the conditioned stimulus (CS) was analyzed with the same criteria for the detection of adaptive conditioned response (significant changes in EMG activity during a 200-msec window immediately before the onset of the unconditioned stimulus). The frequency of responding was comparable between control (black) and CNO-treated hM3Dq-expressing (hM3Dq-CNO, red) rats. Error bars indicate the standard error of mean.
Figure S3. Related to Figure 3. CS-evoked oscillation amplitude varied little across conditioning sessions
A. The averaged normalized amplitude in four pre-determined frequency bands were separately calculated in each session (the lightest shade corresponds to the first session, and the deepest shade corresponds to the last session). The amplitude was calculated up to the time point closest to the US onset without any contamination of the unconditioned stimulus (US) artifact. In all sessions, the normalized amplitude of theta, beta, and gamma activity in the control group increased during the conditioned stimulus (CS). After offset of the CS, the amplitude dropped either to below or to the baseline level. The amplitude of delta activity did not change upon the presentation of CS. B. In CNO-treated hM3Dq-expressing rats, following the increase of amplitude during the CS, the amplitude of theta, beta, and gamma activity gradually increased toward the US onset. This ramping activity was observed during the first session, and the degree of ramping was comparable across all sessions. The amplitude of delta activity did not change upon the presentation of CS. Two grey lines show the onset and offset of CS.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Subjects
Thirty-six male Long-Evans rats (Charles River Laboratories, St. Constant, QC, Canada), 70 days old upon arrival, were individually housed in transparent plastic cages in a home colony room and maintained on a 12-hour reverse light/dark cycle (dark from 10:00 to 22:00) with free access to food and water. Their weight ~one week after their arrival ranged from 350-425 g. Behavioral experiments were performed during the dark cycle. All procedures were in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication NO. 85-23, revised 1985) , the Canadian Council on Animal's Care, APA ethical standard, and approved by the University of Toronto Animal Care Committee.
Viral Vectors
Recombinant adeno-associated virus (rAAV) vectors encoding the Designer Receptors Exclusively Activated by Designer Drug (DREADD); (Armbruster et al., 2007; Rogan and Roth, 2011) or enhanced green fluorescent protein (eGFP) were obtained from the UNC Vector Core (University of North Carolina, Chapel Hill, NC). The following vectors were used: rAAV2/8-CamKIIa-eGFP (4×10 12 viral particles (vp)/ml) and rAAV2/8-CamKIIahM3D (Gq)-mCherry (2.2×10 12 vp/ml).
Surgery
Rats underwent two surgery protocols: they first received the viral vector (1) and after then an incubation period were implanted with local field potential (LFP) and electromyogram (EMG) electrodes (2).
Viral vector surgery (1)
Rats were randomly assigned to receive injections of either rAAV2/8-CamKIIahM3D(Gq)-mCherry (hM3Dq group) or rAAV2/8-CamKIIa-eGFP (GFP group). One week after their arrival in the facility, rats were anesthetized (1-2% isoflurane by volume in oxygen at a flow rate of 1.5 L/min; Holocarbon Laboratories, River Edge, NJ, USA) and placed in a stereotaxic frame. Skin was retracted and holes drilled in the skull bilaterally above the prelimbic region of the medial prefrontal cortex [anteroposterior (AP) = +3.2, mediolateral (ML) = ±0.5 from bregma; Paxinos and Watson, 2007] . A 30-G stainless steel cannula was connected to a microsyringe (Hamilton, Reno, NV) via polyethylene tubing and lowered to 3.5 mm below bregma. Viral vector (0.5 μl/side) was injected at a rate of 0.1 μl/min. The cannula was left in place an additional 5 min following the microinjection to ensure the diffusion of the vector. The cannula was then slowly retracted, and the incision was sutured. The rats were treated with analgesic (ketoprofen, 5 mg/kg, s.c.) for 48 hours after surgery and left in their home cage for six weeks.
Electrodes surgery (2) LFP electrodes were fabricated by inserting two short pieces of stainless steel wire (No. 791000; A-M Systems, Carlsborg, WA, USA) into a 25-G stainless steel cannula (distance between electrodes tips was 0.7mm). As described in (1), rats were anesthetized and placed in a stereotaxic frame. After craniotomy and removal of dura, an electrode was implanted in the prelimbic region of medial prefrontal cortex (AP = +3.2, ML = +0.6, DV = -3.9 mm from bregma) contralateral (right) to the conditioned eye. In addition, four Teflon-coated stainless-steel wires attached to a connector cap (Ginder Scientific, Nepean, ON, Canada) were positioned subcutaneously in the upper left orbicularis oculi (eyelid muscle) to record EMG activity and deliver a periorbital shock. The EMG and LFP electrodes were secured to the skull with stainless steel screws and dental acrylic resin. The rats were given an analgesic treatment [see (1)] and at least seven days to recover from surgery before beginning daily conditioning sessions.
Histology
Upon the completion of behavioral testing, brain tissue was collected to conduct four experiments to address the following points: A, the location and spread of viral vector infection; B, the location of LFP electrodes; C, the selective expression of hM3Dq in the pyramidal neurons; D, the in vivo validation of the effects of CNO treatment on hM3Dq-expressing cells.
Tissue collection Rats were subcutaneously injected with either CNO (0.1 mg/kg body weight) or 0.9% physiological saline solution in their home cage. Ninety minutes later, rats were deeply anesthetized with an excess amount of sodium pentobarbital (102 mg/kg; Euthansol, Merck, Kirkland, QC, Canada), and the tips of the LFP electrodes were marked by electrolytic lesions (20 µA for 45 s, positive to electrode, negative to animal ground). They were perfused transcardially with chilled 0.9% physiological saline solution, followed by chilled 4% Paraformaldehyde (PFA). Brains were extracted and left submerged within 4% PFA at 4°C for two hours, followed by Phosphate Buffered Saline -30% Sucrose solution (PBS-Suc) for 48 hours. Coronal brain slices (40 μm) across the entire anterior-posterior extent of the medial prefrontal cortex were collected using a cryostat (CM3050S, Leica Biosystems, Nussloch, Germany). Every first and second tissue section was stored in a separate tube filled with Tissue Storage Buffer (TSB, PBS with sucrose and ethylene glycol solution), whilst every third tissue section was stored in PBS, all tubes aside from those stored in only PBS were then stored at -20°C. Each tube was used for the experiment A, B, and C. In some rats, coronal brain sections (30 μm) were collected for experiment D and stored in TSB at -20°C.
Location and extent of viral infection
For experiment A, sections were mounted on a glass slide and cover-slipped with ProLong® Diamond antifade mounting medium containing DAPI (Thermo Fisher Scientific, Waltham, MA, USA). Endogenous mCherry signal was used to determine the placement and extent of viral infection for each rat. Rats which received rAAV2/8-CamKIIa-hM3D(Gq)-mCherry were included in subsequent analyses if robust mCherry expression was observed in the prelimbic region in at least one hemisphere.
Location of LFP electrodes
For experiment B, tissue was mounted on a glass slide and stained with cresyl violet. It was subsequently examined under a light microscope, and the locations of the electrode tips were drawn on to plates from the stereotaxic atlas of the rat brain (Paxinos and Watson, 2007) . All data from the animals whose electrodes were not located in the prelimbic region were omitted from the analyses.
Immunostaining For experiments C and D, sections were removed from TSB, washed in PBS, and submerged in goat serum (#ab156046, Abcam, Cambridge, MA, USA) for one hour at room temperature. The sections were then washed three times with Phosphate Buffered Saline -0.1% Triton X-100 Detergent (PBS-T). Then, they were incubated with a primary antibody against c-Fos (Rabbit, #2250, 1:400, Cell Signaling Technology, Beverly, MA, USA) or a primary antibody against α-CAMKII (Mouse, #sc-13141, 1:100, Santa Cruz Biotechnology, Dallas, TX, USA) at 4°C overnight. Subsequently, the sections were washed three times using PBS-T and then incubated in a secondary anti-rabbit IgG antibody conjugated with ALEXA 488 (Goat, #111-545-003, 1:400, Jackson ImmunoResearch, West Grove, PA, USA) or a secondary goat anti-mouse IgG antibody conjugated with ALEXA 488 (#115-545-146, 1:400, Jackson ImmunoResearch, West Grove, PA, USA) for two hours at room temperature. The sections were washed three times with PBS-T and underwent nuclear staining with DAPI (#32670-5MG-F, 1:400, Sigma-Aldrich, St. Louis, MO, USA) for five minutes. After three washes with PBS, the sections were mounted on glass slides and sealed with coverslips and Cytoseal 280 (#8311-4, Thermo Fisher Scientific, Waltham, MA, USA).
Image acquisition Images were collected from the immunostained tissue using a confocal microscope (AxioObserver Z1 Imager, Zeiss, Jena, Germany) with a 20x objective. Areas of analysis consisted of a 0.45 × 0.45-mm region on the XY scale and were Z-sectioned in 1.0-μm optical sections. A section with the track of cannula used for the viral vector injection was identified. Then, an image was taken from an area adjacent to the injection track. Four images were collected from the prelimbic region from each rat.
Cell counting Collected images were manually analyzed by two experimenters who were blind to the treatment condition with the help of FIJI (ImageJ) software. In each image, the number of DAPI-positive cells were marked and counted. Small, bright uniformly DAPI stained nuclei from putative glial cells were not included in the DAPI counts. The number of DAPI-positive cells which were also positive for c-Fos-, α-CAMKIIimmunoreactivity, or hM3Dq (detected as mCherry signal) were counted. The raw count was converted to a ratio for each image and then averaged across the four images for each animal.
Statistical analyses
The data presented is the group's mean ± the group's standard error of the mean. The difference between groups was calculated by t-test.
Behavioral Analyses
Virus / Drug assignments At least six weeks after the intracranial injection of rAAV2/8-CamKIIahM3D(Gq)-mCherry (hM3Dq group) or rAAV2/8-CamKIIa-eGFP (GFP group), the rats were randomly assigned to receive subcutaneous injections of either CNO solution (0.1 mg/kg body weight) or 0.9% saline solution (SAL) thirty minutes before daily conditioning sessions (starting from the second adaptation session). This generated four groups, hM3Dq-SAL (n=5), hM3Dq-CNO (n=12), GFP-SAL (n=7), and GFP-CNO groups (n=8).
Trace eyeblink conditioning All rats were trained in trace eyeblink conditioning for nine days. Animals were placed into a transparent, cylindrical, plastic container and put into a sound and light-attenuating chamber. For the first two sessions, the rats were placed in the conditioning chamber for one hour without any stimulus presentations in order to habituate them to the procedures and chamber. Starting on the third session, rats received pairings of the conditioned stimulus (CS, 100-ms, 2.5-kHz, 85-dB pure tone) and the unconditioned stimulus (US, 100-ms, 100-Hz, mild periorbital shock) which were separated by a 750-ms stimulus-free interval. Daily sessions consisted of ninety CS-US pairings and ten CS only trials (every tenth trial) over the course of fifty minutes. The inter-trial intervals were pseudo-randomized between 20 s and 40 s with a mean of 30 s. Stimulus delivery was controlled by a microcontroller (BasicX, Netmedia, Tucson, AZ, USA). The CS was delivered through a speaker in the chamber ceiling, and the US was delivered to the eyelid with a stimulus isolator (ISO-Flex, A.M.P.I., Jerusalem, Israel). The shock level was initiated at 0.3 mA and was adjusted individually and daily for each rat to induce an optimal unconditioned response (UR; an eyeblink/head-turn response) which was monitored through web-cameras mounted inside the chambers. The conditioned response (CR) was defined as eyeblink responses elicited during a 200-ms window immediately before US onset. Eyeblink responses were monitored by recording EMG activity from the left upper orbicularis oculi muscle through two surgically implanted stainless steel wires. EMG activity was band-pass filtered between 0.3 and 3.0 kHz, digitized at 6,102 Hz, and stored using a RZ-5 recording system (Tucker-Davis Technologies, Alachua, FL, USA). Data for each group was collected from at least two different batches of conditioning to ensure that any observed effect was replicable.
EMG analysis All analyses were performed using custom code written in Matlab (Mathworks,Natick, MA, USA; see also Morrissey et al., 2012; Tanninen et al., 2015) . For each session per animal, the amplitude of the EMG signal during each 1 ms of time was calculated by subtracting the minimum signal from the maximum signal during that 1-ms window. EMG amplitude was averaged during a 300-ms window before CS presentation in each trial. The baseline was set as the median of averaged EMG amplitude plus one standard deviation. EMG activity above the threshold was averaged together during the 300-ms pre-CS period (pre-value) and during a 200-ms window before US onset (CR value). The CR value was designed to capture the adaptive blinking responses that occur immediately before US onset. A trial was defined as a CR trial if the CR value was at least five times that of the pre-value. Trials in which the pre-value exceeded 30% of threshold were discarded. The percent of conditioned responding (CR%) for each animal in a given session was the ratio of CR trials relative to the total number of valid trials. To examine the temporal specificity of eyeblink responses, the same detection criteria were applied to EMG activity during the CS to calculate the frequency of blinking that was not time-locked to the onset of US. To examine the temporal pattern of EMG activity, EMG amplitude was averaged across all valid trials. To examine the effect of chemogenetic manipulation on the frequency of spontaneous blinking, the EMG activity during the second adaptation session was analyzed with the same detection criteria for CRs. In addition, the latency to the onset and peak of the CR in the last acquisition session was calculated in each trial and each animal. The values were averaged across trials, then across animals in each group.
Statistical analyses
The data presented is the group's mean for each day of conditioning ± the group's standard error of the mean (CR%). Repeated measures analysis of variance (ANOVAs), with drug-viral vector combination as a between-subjects factor and session as a within-subjects factor were used to determine statistical significance. The onset and peak latency of CR were compared between groups by t-test.
Electrophysiological Analyses
LFP Recording LFPs were measured as the voltage difference between the two tips of a bipolar electrode (the difference in the length was 0.7 mm) and continuously recorded during daily conditioning. LFPs were amplified by 1000 times, filtered between 1 and 400 Hz, and digitized at 2,034 Hz with the same RZ-5 recording system used for the recording of EMG activity.
Pre-processing All trials (regardless of US presentation) were included in the analysis, and the results were pooled. To remove trials with movement artifact, a threshold was defined as the across-trial mean plus four standard deviations of the raw LFP signals during a 500-ms period before CS onset. This threshold was selected based on visual inspection of several datasets. If LFP signals during a 500-ms period before CS onset exceeded this threshold in a trial, the trial was excluded from further analyses. Subsequently, the power spectrum density was calculated to ensure that its shape was consistent with those reported in previous studies (Insel et al., 2012; Paz et al., 2008) . If the power spectrum contained a large peak at 60Hz (power line noise), we assumed connection failure and did not use the data for further analysis (n = 5).
Spectrogram Time-frequency analyses were conducted on raw LFP data during the last acquisition session by means of the Morlet wavelets method, using the ft_freqanalysis function from the FieldTrip toolbox (Oostenveld, et al., 2011) . To detect changes in oscillatory activity induced by CS presentation, the power in each frequency band was divided by the averaged power during a 1-sec window before the CS presentation.
Amplitude during the CS and trace interval To detect CS-induced changes in oscillatory activity, we computed instantaneous amplitude by using the Hilbert transform. This method was chosen over other methods because of its high temporal resolution. The amplitude of four pre-determined frequency bands (delta, 2-4 Hz; theta, 4-12 Hz; beta, 12-30 Hz; gamma, 30-80 Hz) during the CS and interval between the CS and US (trace interval) was computed with the following steps. First, in each trial, raw LFP signals during a 2-second window around CS onset were filtered with a bandpass filter (third order Chebyshev Type 1, forward and backward for zero phase distortion using the filtfilt function in MATLAB). Second, the instantaneous amplitude was calculated as the absolute value of the Hilbert transform of the filtered signal. Third, the amplitude was divided by the averaged amplitude during a 500-msec window before the CS onset. Forth, the normalized amplitude was averaged in a series of 100-msec time windows from 300 msec before the CS onset to the last window closest to the US onset without any contamination of US artifact (the end of last time widow from CS onset, 300 ms for delta; 600 ms for theta; 700 ms for beta; 700 ms for gamma). Fifth, the values were averaged across trials, then across sessions, and finally across animals in each group.
EMG-LFP correlations
To examine changes in LFP activity induced by eyelid movement, we analyzed the data recorded during the second adaptation session. Following analysis was applied on the data from fifteen rats in which the LFP and EMG signals were free of power line noise. Segments of spontaneous eyeblinks were identified with the following steps. First, the amplitude of EMG was calculated as the root mean squared value of raw EMG signals in a series of 500-ms sliding time windows. Then, the upper threshold was defined as the mean plus ten standard deviations, and the lower threshold was defined as the mean plus two standard deviations. Time points at which the EMG amplitude reached the upper threshold were detected. In each of these time points, we searched for nearby time points at which the EMG amplitude crossed the lower threshold in forward and backward directions. These time points were defined as the onset and offset of 'spontaneous eyeblink' period. To validate the eyeblink period, the averaged EMG amplitude was calculated during a 50-msec window before and after the onset of each eyeblink period. If the latter was at least two times larger than the former, the period was included in subsequent analyses. Finally, LFP signals in a 4-sec time window around the onset of eyelid period were extracted, analyzed with the same method as those described in Spectrogram.
Statistical analyses For the comparison of normalized amplitude between the groups or trial types, the data were presented as the mean of normalized amplitude across samples (one sample corresponds to the normalized amplitude in one rat in one session) ± the standard error of the mean. Unpaired or paired t-test with Bonferroni corrections was used to determine statistical significance.
